LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

A. Pardanani, T. Lasho, C. Finke, S. T. Oh, J. Gotlib, A. Tefferi

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences